TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI August 15, 1986
TCL Archive Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial March 28, 2014
TCL Archive In Brief: Pay raise Must Come From Intramural Funds, Not Extramural, Administration Says May 9, 1980
